-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Arcutis Biotherapeutics, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2018 to 2024.
- Arcutis Biotherapeutics, Inc. Operating Income (Loss) for the quarter ending June 30, 2025 was -$14.6M, a 70.8% increase year-over-year.
- Arcutis Biotherapeutics, Inc. Operating Income (Loss) for the twelve months ending June 30, 2025 was -$85.8M, a 52.3% increase year-over-year.
- Arcutis Biotherapeutics, Inc. annual Operating Income (Loss) for 2024 was -$128M, a 46.7% increase from 2023.
- Arcutis Biotherapeutics, Inc. annual Operating Income (Loss) for 2023 was -$241M, a 20.1% increase from 2022.
- Arcutis Biotherapeutics, Inc. annual Operating Income (Loss) for 2022 was -$302M, a 46% decline from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)